MedTrace Logo

Optimizing Phototesting and Investigating Photobiology of Visible Light

NCT05964907 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2026-05-01

No results posted yet for this study

Summary

Specific Aim 1: To determine the impact of spectral composition of the VL+UVA1 source on the associated biologic effects.

Specific Aim 2: To investigate differential responses of subjects with different skin phototypes to VL+UVA1, including immediate and delayed erythema and pigmentation, and photodamage.

Conditions

  • Healthy

Interventions

DEVICE

Light Source B: Visible Light solar simulator (VL + UVA1)

Patients will be radiated with light source B (Visible light solar simulator)

DEVICE

Light Source A: Visible Light solar simulator closer match to sunlight (VL +UVA1)

Patients will be radiated with light source A (Visible light solar simulator closer match to sunlight)

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Indermeet Kohli, PhD · Henry Ford Health Dermatology Research

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-06
Primary Completion
2026-12-30
Completion
2026-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05964907 on ClinicalTrials.gov